<p>Orcinol glucoside facilitates the shift of MSC fate to osteoblast and prevents adipogenesis via Wnt/β-catenin signaling pathway</p>

Xinying Zhou, Zezheng Liu, Bin Huang, Huibo Yan, Changsheng Yang, Qingchu Li, Dadi Jin

Open source

DOI
10.2147/dddt.s208458
Published
2019-08
Container
Drug Design, Development and Therapy
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/dddt.s208458,
  title = {\<p\>Orcinol glucoside facilitates the shift of MSC fate to osteoblast and prevents adipogenesis via Wnt/β-catenin signaling pathway\</p\>},
  author = {Xinying Zhou and Zezheng Liu and Bin Huang and Huibo Yan and Changsheng Yang and Qingchu Li and Dadi Jin},
  year = {2019},
  journal = {Drug Design, Development and Therapy},
  doi = {10.2147/dddt.s208458},
  url = {https://doi.org/10.2147/dddt.s208458}
}

RIS

TY  - JOUR
TI  - <p>Orcinol glucoside facilitates the shift of MSC fate to osteoblast and prevents adipogenesis via Wnt/β-catenin signaling pathway</p>
AU  - Xinying Zhou
AU  - Zezheng Liu
AU  - Bin Huang
AU  - Huibo Yan
AU  - Changsheng Yang
AU  - Qingchu Li
AU  - Dadi Jin
PY  - 2019
JO  - Drug Design, Development and Therapy
DO  - 10.2147/dddt.s208458
UR  - https://doi.org/10.2147/dddt.s208458
ER  - 

APA

Zhou, X., Liu, Z., Huang, B., Yan, H., Yang, C., Li, Q., & Jin, D. (2019). <p>Orcinol glucoside facilitates the shift of MSC fate to osteoblast and prevents adipogenesis via Wnt/β-catenin signaling pathway</p>. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s208458

Source records